BMEA vs RVTY · $94.7M cap vs P/E 42, rev $2.76B
Biomea Fusion Inc (BMEA) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported RVTY revenue for 2024-12-29 was $2.76B. Net income was $270.4M. Revenue was up 0.2% from 2023-12-31 to 2024-12-29. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
BMEA currently screens at market cap $94.7M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the BMEA and RVTY stock pages for the full models.
Not investment advice.